ParaZero Strengthens Global Sales Leadership with Appointment of Bat-Sheva Noy as VP
MWN-AI** Summary
ParaZero Technologies Ltd. (Nasdaq: PRZO), an innovator in the aerospace defense sector focusing on unmanned aerial systems (UAS), has strengthened its global sales leadership with the appointment of Bat-Sheva Noy as the new Vice President of Global Sales. Based in Kfar Saba, Israel, ParaZero aims to enhance its commercial presence in the burgeoning drone safety and aerospace market through Ms. Noy’s extensive expertise.
With over 20 years of experience, Ms. Noy brings a wealth of knowledge in commercial strategy, market access, and team leadership. Her most recent role was as the Business Unit Lead for Rare Diseases at Pfizer Israel, from 2020 to 2025, where she was instrumental in developing strategic initiatives and managing performance for the rare diseases portfolio. Prior to this, she served as the Sales and Marketing Lead at Pfizer Israel, overseeing the sales and marketing of cardiovascular products. Her career at Pfizer spanned from 2004 to 2017, encompassing various sales and managerial roles, and she began her career as a sales representative at GSK Israel.
Educationally, Ms. Noy holds an LL.B. in Law and a B.Sc. in Chemistry and Biology, as well as experience as an optical systems instructor in the Israel Defense Forces. ParaZero believes her diverse background in high-stakes environments makes her a vital asset as the company seeks to innovate and lead in advanced drone technologies.
ParaZero Technologies is recognized for its groundbreaking solutions like SafeAir, an autonomous parachute recovery system, and DefendAir, which offers protection against hostile drones. The company’s vision is to redefine aerial operations with intelligent systems that prioritize safety, scalability, and security.
MWN-AI** Analysis
**Market Advice: Evaluating ParaZero's Leadership Move**
The recent appointment of Bat-Sheva Noy as the Vice President of Global Sales at ParaZero Technologies Ltd. (Nasdaq: PRZO) offers a distinctive opportunity for investors looking at the aerospace defense sector. With her extensive experience in strategic planning and market access, particularly from her tenure at Pfizer Israel, Noy is poised to enhance ParaZero's expansion ambitions, particularly in the burgeoning drone safety and aerospace market.
ParaZero’s focus on autonomous solutions, including its SafeAir parachute recovery system and the DefendAir counter-UAS platform, aligns well with growing regulatory and safety concerns in the drone industry. The increasing investments in UAS technology underscore the importance of companies like ParaZero that prioritize safety and efficiency. Noy's impressive background in building teams and driving business performance can significantly bolster ParaZero’s market presence amidst growing competition.
Investors should consider the implications of Noy's appointment in the context of the company's strategic goals. ParaZero’s mission to redefine aerial operations with intelligent systems suggests a forward-thinking approach aligned with market needs. However, potential investors must remain mindful of the challenges highlighted in their forward-looking statements, particularly uncertainties that could affect actual performance.
In light of these developments, investors might find it prudent to monitor ParaZero's performance closely over the next few quarters. The focus on global expansion and the integration of innovative technologies could be indicative of a growth trajectory that, if executed effectively, offers promising returns.
In summary, while potential risks exist, the recruitment of seasoned leadership like Noy could be a catalyst for ParaZero's growth, making it a stock to watch for long-term investors seeking exposure in the aerospace and defense sectors. As always, investors should perform thorough due diligence and consider market conditions before making investment decisions.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Kfar Saba, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, recently announced the appointment of Bat-Sheva Noy as its new Vice President of Global Sales.
Ms. Noy brings more than 20 years of extensive commercial and leadership experience, with particular expertise in strategic planning, market access, and leading cross-functional teams. Most recently, from 2020 to 2025, she served as the Business Unit Lead for Rare Diseases at Pfizer Israel (a subsidiary of Pfizer Inc., NYSE: PFE). In that role, she was responsible for developing and executing strategy, building and developing teams, and driving overall business performance in the rare diseases portfolio.
Prior to that position, she held the role of Sales and Marketing Lead at Pfizer Israel from 2017 to 2019, where she oversaw national sales and marketing operations specifically for the company's cardiovascular product lines.
Her earlier career at Pfizer Israel spanned 2004 to 2017, during which she held various sales and managerial positions. Before joining Pfizer, she worked as a sales representative at GSK Israel from 2002 to 2004.
Educationally, Ms. Noy holds an LL.B. in Law from The Academic Centre of Law and Science in Israel, as well as a B.Sc. in Chemistry and Biology from Tel Aviv University. She also served in the Israel Defense Forces (IDF) as an optical systems instructor in the electro-optics unit.
ParaZero Technologies believes that Ms. Noy's deep experience and leadership background are key strengths that she will bring to the role, supporting the company's efforts to expand its global commercial presence in the growing drone safety and aerospace sector.
About ParaZero Technologies
ParaZero Technologies Ltd. (Nasdaq: PRZO) is an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry. Founded in 2014 by aviation professionals and drone industry veterans, ParaZero is a recognized leader in advanced drone technologies, supporting commercial, industrial, and governmental operations worldwide. The company’s product portfolio includes SafeAir, an autonomous parachute recovery system designed for aerial safety and regulatory compliance; DefendAir, a counter-UAS net-launching platform for protection against hostile drones in both battlefield and urban environments; and DropAir, a precision aerial delivery system. ParaZero’s mission is to redefine the boundaries of aerial operations with intelligent, mission-ready systems that enhance safety, scalability, and security. For more information, visit https://parazero.com.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act and other securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, ParaZero is using forward-looking statements when it discusses expanding its global commercial presence in the growing drone safety and aerospace sector. Forward-looking statements are not historical facts, and are based upon management’s current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management’s expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company’s reports filed from time to time with the Securities and Exchange Commission (“SEC”), including, but not limited to, the risks detailed in the Company’s Annual Report on Form 20-F filed with the SEC on March 21, 2025. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. ParaZero is not responsible for the content of third-party websites.
Investor Relations Contact:
Michal Efraty
Investor Relations
michal@efraty.com
FAQ**
How will the appointment of Bat-Sheva Noy as Vice President of Global Sales impact the growth strategy of ParaZero Technologies Ltd. (Nasdaq: PRZO) in the competitive UAS market?
What specific initiatives does ParaZero Technologies Ltd. (Nasdaq: PRZO) plan to implement under Ms. Noy’s leadership to enhance its global commercial presence in drone safety?
How does ParaZero Technologies Ltd. (PRZO) anticipate leveraging Ms. Noy’s experience from Pfizer to drive innovation and strategic planning in the aerospace defense sector?
What are the key market challenges that ParaZero Technologies Ltd. (Nasdaq: PRZO) expects to face as it seeks to expand its business in the growing drone safety and aerospace sector?
**MWN-AI FAQ is based on asking OpenAI questions about ParaZero Technologies Ltd. (NASDAQ: PRZO).
NASDAQ: PRZO
PRZO Trading
33.22% G/L:
$0.96 Last:
53,901,103 Volume:
$0.70 Open:
